Art

J-GLOBAL ID：201802243278017955   Reference number：18A1381632

Oncolytic Viruses: The Best is Yet to Come

腫瘍溶解性ウイルス:最も良いものである【JST・京大機械翻訳】

Author (5)： Lemay Chantal G. (Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada) ,  Keller Brian A. (Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada) ,  Edge Robert E. (Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada) ,  Abei Masato (Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan) ,  Bell John C. (Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada)
Material： Current Cancer Drug Targets
Volume： 18  Issue： 2  Page： 109-123  Publication year： 2018 
JST Material Number： W3571A  ISSN： 1568-0096  Document type： Article
Article type： 文献レビュー  Country of issue： Unknown (ARE)  Language： ENGLISH (EN)

Abstract/Point： Oncolytic viruses are a promis...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1381632&from=J-GLOBAL&jstjournalNo=W3571A") }}

Thesaurus term： tumor immunity ,  blood flow ,  optimization ,  arsenic ,  therapy ,  Safety ,  *combination therapy ,  microenvironment ,  Tumor vessel ,  Tumor Microenvironment ,  *Oncolytic Viruses ,  modification
Semi thesaurus term： 癌治療 ,  ウイルス療法 ,  臨床研究 ,  *腫瘍溶解性ウイルス , 【Automatic Indexing@JST】

Author keywords (6)： Cancer therapy ,  combination therapy ,  immunity ,  oncolytic viruses ,  tumour microenvironment ,  virotherapy.

JST classification (3)： Experimental treatment for tumors  (GE02040Y) ,  Immunotherapy for tumors  (GE03035B) ,  Virus physiology in general  (EG04041H)

Terms in the title (1)： 腫瘍溶解性ウイルス